Nomura: Chroma revenue beats expectations as gross margin falls; Nomura looks to testing demand in 2027
A higher share of cell turnkey business in the third quarter of 2026 lifted revenue above expectations while diluting gross margin. Nomura raised its earnings forecasts but lowered its target price after reducing its valuation multiple.